To determine whether CHI3L1 is actually a viable candidate therapeutic approach (as a potential drug target) in lung cancer, we examined the association between CHI3L1 and lung cancer using the Open Targets Platform. This evidence concerns the gene CHI3L1 and lung carcinoma.